# US 2023/0144292 A1 · Irak degraders and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0144292 A1
- Document ID: US20230144292A1
- Status: Published application
- Kind: A1
- Application number: 18/045,394
- Filed: 2022-10-10
- Published: 2023-05-11
- Earliest claimed: 2019-12-17
- Assignees: Kymera Therapeutics, Inc.
- Applicants: Kymera Therapeutics, Inc.
- Inventors: Matthew M. WEISS
- Web page: https://patentgrep.com/patent/US20230144292A1

## CPC

- A61K 31/4545: containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A61K 47/55: the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
- A61K 31/4725: containing further heterocyclic rings
- A61K 31/497: containing further heterocyclic rings
- A61K 31/501: not condensed and containing further heterocyclic rings
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 47/545: {Heterocyclic compounds (A61K47/558 takes precedence)}
- A61P 35/00: Antineoplastic agents
- C07D 417/14: containing three or more hetero rings
- C07D 487/04: Ortho-condensed systems
- C07D 513/04: Ortho-condensed systems
- C07D 513/14: Ortho-condensed systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

A compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.

### Claim 15 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 16 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 17 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 18 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 19 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 20 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 21 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 22 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 23 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 24 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 25 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 26 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 27 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 28 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 29 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 30 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 31 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 32 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 33 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 34 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 35 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 36 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 37 (depends on 14)

The compound of claim 14, wherein said compound is
and or a pharmaceutically acceptable salt thereof.

### Claim 38 (depends on 14)

The compound of claim 14, wherein said compound is
or a pharmaceutically acceptable salt thereof.

### Claim 39

A pharmaceutical composition comprising a compound selected from the group consisting of
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.

### Claim 40 (depends on 39)

The pharmaceutical composition of claim 39, wherein said compound is selected from the group consisting of:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.

### Claim 41 (depends on 39)

The pharmaceutical composition of claim 39, wherein said compound is selected from the group consisting of:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.

### Claim 42 (depends on 39)

The pharmaceutical composition of claim 39, wherein said compound is selected from the group consisting of:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.

### Claim 43 (depends on 39)

The pharmaceutical composition of claim 39, wherein said compound is selected from the group consisting of
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
